152 related articles for article (PubMed ID: 31307673)
21. CANINE DISTEMPER VIRUS ANTIBODY TITERS IN DOMESTIC CATS AFTER DELIVERY OF A LIVE ATTENUATED VIRUS VACCINE.
Ramsay E; Sadler R; Rush R; Seimon T; Tomaszewicz A; Fleetwood EA; McAloose D; Wilkes RP
J Zoo Wildl Med; 2016 Jun; 47(2):551-7. PubMed ID: 27468028
[TBL] [Abstract][Full Text] [Related]
22. Investigation of multiple Felis catus papillomavirus types (-1/-2/-3/-4/-5/-6) DNAs in feline oral squamous cell carcinoma: a multicentric study.
Altamura G; Cuccaro B; Eleni C; Strohmayer C; Brandt S; Borzacchiello G
J Vet Med Sci; 2022 Jun; 84(6):881-884. PubMed ID: 35431284
[TBL] [Abstract][Full Text] [Related]
23. Genomic characterisation of Felis catus papillomavirus 4, a novel papillomavirus detected in the oral cavity of a domestic cat.
Dunowska M; Munday JS; Laurie RE; Hills SF
Virus Genes; 2014 Feb; 48(1):111-9. PubMed ID: 24242846
[TBL] [Abstract][Full Text] [Related]
24. Felis catus papillomavirus types 1 and 4 are rarely present in neoplastic and inflammatory oral lesions of cats.
Munday JS; French AF
Res Vet Sci; 2015 Jun; 100():220-2. PubMed ID: 25795095
[TBL] [Abstract][Full Text] [Related]
25. Identification of A Novel Papillomavirus Associated with Squamous Cell Carcinoma in A Domestic Cat.
Carrai M; Van Brussel K; Shi M; Li CX; Chang WS; Munday JS; Voss K; McLuckie A; Taylor D; Laws A; Holmes EC; Barrs VR; Beatty JA
Viruses; 2020 Jan; 12(1):. PubMed ID: 31968684
[TBL] [Abstract][Full Text] [Related]
26. The discovery of novel papillomaviruses in cats in Southwest China.
Zhou Q; Yu J; Song X; Zhang J; Zhang B
Virus Genes; 2023 Jun; 59(3):484-488. PubMed ID: 36976417
[TBL] [Abstract][Full Text] [Related]
27. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
[TBL] [Abstract][Full Text] [Related]
28. Frequent detection of papillomavirus DNA in clinically normal skin of cats infected and noninfected with feline immunodeficiency virus.
Munday JS; Witham AI
Vet Dermatol; 2010 Jun; 21(3):307-10. PubMed ID: 20042039
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial.
Poland GA; Jacobson RM; Koutsky LA; Tamms GM; Railkar R; Smith JF; Bryan JT; Cavanaugh PF; Jansen KU; Barr E
Mayo Clin Proc; 2005 May; 80(5):601-10. PubMed ID: 15887427
[TBL] [Abstract][Full Text] [Related]
30. TIGER (
McEntire M; Ramsay EC; Kania S; Prestia P; Anis E; Cushing AC; Wilkes RP
J Zoo Wildl Med; 2020 Jan; 50(4):798-802. PubMed ID: 31926509
[TBL] [Abstract][Full Text] [Related]
31. Involvement of
Ito S; Chambers JK; Sumi A; Yamashita-Kawanishi N; Omachi T; Haga T; Nakayama H; Uchida K
Vet Pathol; 2022 Jan; 59(1):63-74. PubMed ID: 34510979
[TBL] [Abstract][Full Text] [Related]
32. Feline papillomas and papillomaviruses.
Sundberg JP; Van Ranst M; Montali R; Homer BL; Miller WH; Rowland PH; Scott DW; England JJ; Dunstan RW; Mikaelian I; Jenson AB
Vet Pathol; 2000 Jan; 37(1):1-10. PubMed ID: 10643975
[TBL] [Abstract][Full Text] [Related]
33. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
34. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.
Emeny RT; Wheeler CM; Jansen KU; Hunt WC; Fu TM; Smith JF; MacMullen S; Esser MT; Paliard X
J Virol; 2002 Aug; 76(15):7832-42. PubMed ID: 12097595
[TBL] [Abstract][Full Text] [Related]
35. Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
Brown DR; Fife KH; Wheeler CM; Koutsky LA; Lupinacci LM; Railkar R; Suhr G; Barr E; Dicello A; Li W; Smith JF; Tadesse A; Jansen KU
Vaccine; 2004 Jul; 22(21-22):2936-42. PubMed ID: 15246630
[TBL] [Abstract][Full Text] [Related]
36. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
37. Genomic characterisation of the feline sarcoid-associated papillomavirus and proposed classification as Bos taurus papillomavirus type 14.
Munday JS; Thomson N; Dunowska M; Knight CG; Laurie RE; Hills S
Vet Microbiol; 2015 Jun; 177(3-4):289-95. PubMed ID: 25840470
[TBL] [Abstract][Full Text] [Related]
38. Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.
Schellenbacher C; Shafti-Keramat S; Huber B; Fink D; Brandt S; Kirnbauer R
Virology; 2015 Dec; 486():284-90. PubMed ID: 26519597
[TBL] [Abstract][Full Text] [Related]
39. Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
Hainisch EK; Abel-Reichwald H; Shafti-Keramat S; Pratscher B; Corteggio A; Borzacchiello G; Wetzig M; Jindra C; Tichy A; Kirnbauer R; Brandt S
J Gen Virol; 2017 Feb; 98(2):230-241. PubMed ID: 28284277
[TBL] [Abstract][Full Text] [Related]
40. Comparison of prevalence of Felis catus papillomavirus type 2 in squamous cell carcinomas in cats between Taiwan and Japan.
Yamashita-Kawanishi N; Chang CY; Chambers JK; Uchida K; Sugiura K; Kukimoto I; Chang HW; Haga T
J Vet Med Sci; 2021 Aug; 83(8):1229-1233. PubMed ID: 34135244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
